SG Americas Securities LLC Reduces Stock Position in Ventas, Inc. (NYSE:VTR)

SG Americas Securities LLC lessened its stake in shares of Ventas, Inc. (NYSE:VTRGet Rating) by 73.9% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,229 shares of the real estate investment trust’s stock after selling 43,038 shares during the quarter. SG Americas Securities LLC’s holdings in Ventas were worth $941,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in VTR. Riverview Trust Co purchased a new stake in Ventas during the 1st quarter worth about $25,000. US Asset Management LLC acquired a new stake in Ventas in the 1st quarter worth about $32,000. MUFG Americas Holdings Corp boosted its stake in Ventas by 60.0% in the 4th quarter. MUFG Americas Holdings Corp now owns 768 shares of the real estate investment trust’s stock worth $39,000 after buying an additional 288 shares during the last quarter. CWM LLC acquired a new stake in Ventas in the 4th quarter worth about $45,000. Finally, Benjamin Edwards Inc. acquired a new stake in Ventas in the 4th quarter worth about $62,000. Hedge funds and other institutional investors own 94.02% of the company’s stock.

Insiders Place Their Bets

In other Ventas news, CEO Debra A. Cafaro sold 17,400 shares of Ventas stock in a transaction that occurred on Wednesday, June 1st. The stock was sold at an average price of $56.43, for a total transaction of $981,882.00. Following the sale, the chief executive officer now directly owns 767,960 shares in the company, valued at approximately $43,335,982.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.30% of the stock is owned by company insiders.

Ventas Price Performance

VTR stock opened at $53.78 on Monday. The company has a quick ratio of 0.62, a current ratio of 0.62 and a debt-to-equity ratio of 1.15. Ventas, Inc. has a 52-week low of $45.44 and a 52-week high of $64.02. The stock’s 50 day moving average is $52.47 and its two-hundred day moving average is $54.93. The company has a market capitalization of $21.50 billion, a PE ratio of 137.90, a P/E/G ratio of 3.34 and a beta of 1.15.

Ventas Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, July 14th. Shareholders of record on Friday, July 1st were issued a dividend of $0.45 per share. The ex-dividend date of this dividend was Thursday, June 30th. This represents a $1.80 annualized dividend and a yield of 3.35%. Ventas’s dividend payout ratio is presently 461.55%.

Analysts Set New Price Targets

VTR has been the topic of a number of research analyst reports. Royal Bank of Canada raised their price target on Ventas from $62.00 to $63.00 in a research note on Friday, May 20th. Deutsche Bank Aktiengesellschaft reduced their price objective on Ventas from $67.00 to $65.00 and set a “buy” rating on the stock in a research note on Wednesday, July 13th. Jefferies Financial Group raised Ventas from a “hold” rating to a “buy” rating and lifted their price objective for the company from $58.00 to $59.00 in a research note on Thursday, June 30th. Barclays reduced their price objective on Ventas from $67.00 to $65.00 and set an “overweight” rating on the stock in a research note on Monday, July 25th. Finally, Raymond James reaffirmed a “maintains” rating on shares of Ventas in a research note on Tuesday, July 26th. One analyst has rated the stock with a sell rating, two have given a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat.com, Ventas has a consensus rating of “Moderate Buy” and a consensus price target of $61.80.

About Ventas

(Get Rating)

Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries – healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population.

See Also

Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTRGet Rating).

Institutional Ownership by Quarter for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.